• Anaesthesia · Mar 2015

    Randomized Controlled Trial

    Use of hyaluronidase as an adjuvant to ropivacaine to reduce axillary brachial plexus block onset time: a prospective, randomised controlled study.

    Hyaluronidase 100 IU/mL when added to ropivacaine speeds onset of axillary nerve blockade.

    pearl
    • W U Koh, H G Min, H S Park, M H Karm, K K Lee, H S Yang, and Y J Ro.
    • Department of Anesthesiology and Pain Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea.
    • Anaesthesia. 2015 Mar 1;70(3):282-9.

    AbstractWhen considering brachial plexus block as a practical alternative to general anaesthesia for upper limb surgery, the time to achieve complete sensory block is a clinically important variable. In this prospective randomised double-blind controlled trial, we investigated the hypothesis that addition of hyaluronidase to ropivacaine may reduce the time to achieve complete sensory block after axillary brachial plexus block. The patients were randomly assigned into a hyaluronidase group (n = 24) and a control group (n = 24). The hyaluronidase group received ropivacaine 0.5% with 100 IU.ml(-1) of hyaluronidase, and the control group received ropivacaine alone. The primary endpoint was the time to achieve complete sensory block. The hyaluronidase group demonstrated significantly shorter mean (SD) sensory block onset time (13.8 (6.0) min) compared with the control group (22.5 (6.3) min, p < 0.0001). Addition of hyaluronidase to ropivacaine resulted in a reduction in the time needed to achieve complete sensory block.© 2014 The Association of Anaesthetists of Great Britain and Ireland.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

    pearl
    1

    Hyaluronidase 100 IU/mL when added to ropivacaine speeds onset of axillary nerve blockade.

    Daniel Jolley  Daniel Jolley
     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…